"Peritoneal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PERITONEUM.
| Descriptor ID |
D010534
|
| MeSH Number(s) |
C04.588.033.513 C04.588.274.780 C06.301.780 C06.844.620
|
| Concept/Terms |
Peritoneal Surface Malignancy- Peritoneal Surface Malignancy
- Malignancy, Peritoneal Surface
- Peritoneal Surface Malignancies
- Surface Malignancy, Peritoneal
- Peritoneal Carcinomatosis
- Carcinomatosis, Peritoneal
- Peritoneal Carcinomatoses
|
Below are MeSH descriptors whose meaning is more general than "Peritoneal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Peritoneal Neoplasms".
This graph shows the total number of publications written about "Peritoneal Neoplasms" by people in this website by year, and whether "Peritoneal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 1 | 4 |
| 1998 | 6 | 3 | 9 |
| 1999 | 5 | 2 | 7 |
| 2000 | 10 | 2 | 12 |
| 2001 | 3 | 0 | 3 |
| 2002 | 2 | 3 | 5 |
| 2003 | 13 | 1 | 14 |
| 2004 | 13 | 2 | 15 |
| 2005 | 9 | 2 | 11 |
| 2006 | 10 | 1 | 11 |
| 2007 | 12 | 2 | 14 |
| 2008 | 9 | 2 | 11 |
| 2009 | 10 | 2 | 12 |
| 2010 | 9 | 1 | 10 |
| 2011 | 10 | 4 | 14 |
| 2012 | 17 | 2 | 19 |
| 2013 | 8 | 3 | 11 |
| 2014 | 14 | 5 | 19 |
| 2015 | 18 | 1 | 19 |
| 2016 | 10 | 1 | 11 |
| 2017 | 15 | 0 | 15 |
| 2018 | 5 | 1 | 6 |
| 2019 | 17 | 3 | 20 |
| 2020 | 29 | 7 | 36 |
| 2021 | 15 | 1 | 16 |
| 2022 | 14 | 0 | 14 |
| 2023 | 15 | 0 | 15 |
| 2024 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peritoneal Neoplasms" by people in Profiles.
-
Systemic Therapy Options for Peritoneal Mesothelioma. J Natl Compr Canc Netw. 2024 10; 22(8).
-
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer. Nature. 2024 Aug; 632(8025):656-663.
-
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis. Gynecol Oncol. 2024 Sep; 188:125-130.
-
Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial. Gynecol Oncol. 2024 Sep; 188:1-7.
-
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study. Ann Surg Oncol. 2024 Jul; 31(7):4726-4734.
-
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res. 2024 04 02; 22(4):329-336.
-
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis. Med. 2024 Apr 12; 5(4):311-320.e3.
-
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2024 May; 31(5):3314-3324.
-
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer. Ann Surg Oncol. 2024 May; 31(5):2824-2825.
-
Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment. Cell Rep. 2024 01 23; 43(1):113613.